Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -1.24% | 63.15 | 1.0% | $510.50m | |
| AMGN | Amgen, Inc. | -4.02% | 225.59 | 1.3% | $451.51m | |
| BIIB | Biogen, Inc. | -2.14% | 278.14 | 1.4% | $375.15m | |
| ILMN | Illumina, Inc. | -2.27% | 319.58 | 3.5% | $322.74m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -2.07% | 229.06 | 1.9% | $273.01m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -3.17% | 345.28 | 2.6% | $238.76m | |
| EXAS | EXACT Sciences Corp. | -2.83% | 89.57 | 24.0% | $223.37m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -3.02% | 105.27 | 2.0% | $170.84m | |
| A | Agilent Technologies, Inc. | -0.92% | 88.25 | 1.6% | $130.79m | |
| INCY | Incyte Corp. | -1.92% | 76.74 | 2.5% | $127.16m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.61% | 86.15 | 4.3% | $108.27m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.14% | 112.39 | 14.6% | $108.00m | |
| SGEN | Seattle Genetics, Inc. | -1.54% | 113.57 | 6.1% | $103.89m | |
| BLUE | bluebird bio, Inc. | -2.74% | 87.26 | 14.2% | $86.40m | |
| DERM | Dermira, Inc. | -0.27% | 18.71 | 3.8% | $83.32m |
Company Profile
Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. It offers proprietary microRNA technologies, such as Rosetta Cancer Origin, mi-KIDNEY, and RosettaGX Reveal Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel.